Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia

Pediatric Pulmonology
|September 1, 1986
PubMed

Insights

Subcutaneous terbutaline significantly improved lung mechanics in infants with severe bronchopulmonary dysplasia (BPD). This bronchodilator enhanced lung compliance and reduced pulmonary resistance, aiding ventilator-dependent infants.

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Severe bronchopulmonary dysplasia (BPD) presents significant challenges in ventilator-dependent infants.
  • Pulmonary mechanics are often severely compromised in these patients.
  • Limited therapeutic options exist to improve respiratory outcomes in severe BPD.

Purpose of the Study:

  • To investigate the physiological effects of subcutaneous terbutaline on pulmonary mechanics.
  • To assess the impact of terbutaline on ventilator-dependent infants with severe BPD.
  • To determine if terbutaline administration improves lung compliance and reduces airway resistance.

Main Methods:

  • A cohort of eight ventilator-dependent infants with severe BPD was studied.
  • Pulmonary mechanics and arterial blood gases were measured before and after terbutaline administration.
  • Subcutaneous terbutaline (5 micrograms/kg) was administered, with measurements taken at 30 and 60 minutes.

Main Results:

  • Significant improvement in lung compliance (38%) observed at 30 and 60 minutes post-administration (p < 0.001).
  • Significant reduction in pulmonary resistance by 23% at 30 minutes and 26% at 60 minutes (p < 0.05).
  • Increased I/E ratio in all patients at 60 minutes (p < 0.01) and clinical improvement in 6/8 infants.

Conclusions:

  • Subcutaneous terbutaline administration leads to significant improvements in pulmonary mechanics in infants with severe BPD.
  • Terbutaline effectively enhances lung compliance and decreases pulmonary resistance.
  • These findings suggest terbutaline as a potential therapeutic agent for improving respiratory function in this vulnerable population.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...